10.33
price down icon4.53%   -0.49
pre-market  Pre-market:  10.33  
loading
Mesoblast Ltd Adr stock is traded at $10.33, with a volume of 214.66K. It is down -4.53% in the last 24 hours and up +3.71% over the past month. Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.
See More
Previous Close:
$10.82
Open:
$10.48
24h Volume:
214.66K
Relative Volume:
1.23
Market Cap:
$1.16B
Revenue:
$7.50M
Net Income/Loss:
$-81.89M
P/E Ratio:
0.3695
EPS:
27.9585
Net Cash Flow:
$-63.58M
1W Performance:
-11.75%
1M Performance:
+3.71%
6M Performance:
+41.31%
1Y Performance:
+345.26%
1-Day Range:
Value
$10.08
$10.49
1-Week Range:
Value
$10.00
$12.04
52-Week Range:
Value
$1.61
$12.18

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
Name
Mesoblast Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
73
Name
Twitter
@Mesoblast
Name
Next Earnings Date
2024-07-29
Name
Latest SEC Filings
Name
MESO's Discussions on Twitter

Compare MESO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MESO 10.33 1.16B 7.50M -81.89M -63.58M 27.96
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-24-24 Upgrade Maxim Group Hold → Buy
Aug-29-24 Upgrade Jefferies Hold → Buy
Jul-23-24 Upgrade Piper Sandler Neutral → Overweight
Aug-31-23 Upgrade Jefferies Hold → Buy
Aug-07-23 Downgrade Maxim Group Buy → Hold
Aug-04-23 Downgrade Piper Sandler Overweight → Neutral
Aug-04-23 Downgrade William Blair Outperform → Mkt Perform
Mar-09-23 Initiated William Blair Outperform
Dec-06-22 Downgrade Jefferies Buy → Hold
Sep-06-22 Initiated Piper Sandler Overweight
Apr-07-21 Upgrade Maxim Group Hold → Buy
Dec-22-20 Downgrade Maxim Group Buy → Hold
Dec-04-20 Downgrade Chardan Capital Markets Neutral → Sell
Oct-22-20 Initiated RBC Capital Mkts Sector Perform
Aug-14-20 Reiterated Maxim Group Buy
May-28-20 Reiterated H.C. Wainwright Buy
Jan-31-19 Resumed H.C. Wainwright Buy
Mar-22-18 Downgrade Credit Suisse Neutral → Underperform
Feb-28-18 Reiterated Cantor Fitzgerald Buy
Aug-31-17 Initiated Oppenheimer Outperform
Jun-08-17 Initiated Cantor Fitzgerald Buy
View All

Mesoblast Ltd Adr Stock (MESO) Latest News

pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 18, 2024

Mesoblast files annual report and meeting notice - Investing.com India

Oct 18, 2024
pulisher
Oct 02, 2024

Mesoblast stock soars to 52-week high, hits $8.7 - Investing.com

Oct 02, 2024
pulisher
Sep 29, 2024

Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch - GlobeNewswire Inc.

Sep 29, 2024
pulisher
Aug 29, 2024

Mesoblast stock gains momentum ahead of 2025 PDUFA dateJefferies - Investing.com

Aug 29, 2024
pulisher
Jul 24, 2024

The Psychology of Mesoblast Ltd ADR Inc. (MESO) Price Performance: Understanding Market Sentiment - The InvestChronicle

Jul 24, 2024
pulisher
Jul 23, 2024

Why Argosy Minerals, Flight Centre, Mesoblast, and Telix shares are sinking today - The Motley Fool

Jul 23, 2024
pulisher
Jul 23, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.50% - Investing.com

Jul 23, 2024
pulisher
Jul 21, 2024

Up 308% in 6 months, why is the Mesoblast share price tumbling today? - The Motley Fool

Jul 21, 2024
pulisher
Jul 17, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.73% - Investing.com

Jul 17, 2024
pulisher
Jul 08, 2024

Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today - The Motley Fool

Jul 08, 2024
pulisher
Jul 08, 2024

What's going on with the Mesoblast share price today? - The Motley Fool

Jul 08, 2024
pulisher
Jul 04, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 1.19% By Investing.com - Investing.com

Jul 04, 2024
pulisher
Jun 21, 2024

Australia shares higher at close of trade; S&P/ASX 200 up 0.34% - Investing.com India

Jun 21, 2024
pulisher
Jun 18, 2024

Australia shares higher at close of trade; S&P/ASX 200 up 1.01% - Investing.com India

Jun 18, 2024
pulisher
Jun 04, 2024

Mesoblast LtdADR (MESO) Price Target Increased by 5.79% to 1.56 - MSN

Jun 04, 2024
pulisher
May 27, 2024

There is no doubt that Mesoblast Ltd ADR (MESO) ticks all the boxes. – Sete News - SETE News

May 27, 2024
pulisher
Apr 29, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.81% - Investing.com

Apr 29, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Apr 17, 2024

Australia stocks lower at close of trade; S&P/ASX 200 down 0.09% By Investing.com - Investing.com

Apr 17, 2024
pulisher
Apr 10, 2024

Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha

Apr 10, 2024
pulisher
Apr 01, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.99% - Investing.com

Apr 01, 2024
pulisher
Mar 26, 2024

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga

Mar 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024
pulisher
Mar 12, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.11% By Investing.com - Investing.com

Mar 12, 2024
pulisher
Mar 07, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.39% By Investing.com - Investing.com

Mar 07, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Dec 28, 2023

Mesoblast Stock Set to Reverse Split on Friday, January 5th (NASDAQ:MESO) - MarketBeat

Dec 28, 2023
pulisher
Jun 19, 2023

Top Penny Stocks for Q3 2023 - Investopedia

Jun 19, 2023
pulisher
Apr 20, 2023

Here’s why Mesoblast shares are in a trading halt today - The Motley Fool Australia

Apr 20, 2023
pulisher
Feb 18, 2022

Class action proposed against biotech Mesoblast after historic collapse in share price - Business News Australia

Feb 18, 2022
pulisher
Dec 18, 2020

The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga

Dec 18, 2020
pulisher
Nov 20, 2020

41 Stocks Moving in Friday's Pre-Market SessionAmarin Corp (NASDAQ:AMRN), Artelo Biosciences (NASDAQ:A - Benzinga

Nov 20, 2020
pulisher
Oct 02, 2020

The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs - Yahoo Finance

Oct 02, 2020
pulisher
Mar 17, 2020

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Mar 17, 2020
pulisher
Mar 10, 2020

The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga

Mar 10, 2020
pulisher
Jan 17, 2020

The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares - Yahoo Finance

Jan 17, 2020
pulisher
Jan 16, 2020

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves I - Benzinga

Jan 16, 2020
pulisher
Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020
pulisher
Nov 21, 2018

The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEOi - Benzinga

Nov 21, 2018
pulisher
Mar 22, 2018

Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse BearishMesoblast (NASDAQ:MESO) - Benzinga

Mar 22, 2018
pulisher
Aug 24, 2017

12 Biggest Mid-Day Losers For ThursdayAvalon Holdings (AMEX:AWX) - Benzinga

Aug 24, 2017
pulisher
Nov 29, 2016

Exclusive Interview With Pluristem Therapeutics Inc.(NASDAQ:PSTI) President Yaky Yanay - Market Exclusive

Nov 29, 2016
pulisher
Jun 08, 2016

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) On Track to Becoming Largest Generics Manufacturer - The Wall Street Transcript

Jun 08, 2016
pulisher
May 11, 2016

Advantage: Australia. Biotechs Surge Ahead in Regenerative Medicine and Immuno-Oncology - Streetwise Reports

May 11, 2016

Mesoblast Ltd Adr Stock (MESO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):